Mai Nakamura

Title: Mai Nakamura: Innovator in Medicinal Chemistry

Introduction

Mai Nakamura is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the treatment of substance-related disorders. Her innovative approach combines established medications to enhance therapeutic outcomes.

Latest Patents

Mai Nakamura holds a patent for a unique combination of brexpiprazole and nalmefene. This patent, titled "Combination of brexpiprazole and nalmefene and use thereof for treating substance-related disorders," describes a medicament that includes brexpiprazole or a pharmaceutically acceptable salt thereof, and nalmefene or a pharmaceutically acceptable salt thereof. The formulation is designed for the prophylaxis or treatment of substance-related disorders, with a focus on alcohol-related disorders. She has 1 patent to her name.

Career Highlights

Throughout her career, Mai Nakamura has worked with notable companies in the pharmaceutical industry. She has been associated with Otsuka Pharmaceutical Company, Limited and H. Lundbeck A/S, where she has contributed her expertise in drug development and innovation.

Collaborations

Mai has collaborated with various professionals in her field, including her coworker Kenji Maeda. Their joint efforts have furthered advancements in medicinal chemistry and therapeutic applications.

Conclusion

Mai Nakamura's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her contributions to the treatment of substance-related disorders highlight the importance of combining existing medications for improved patient outcomes.